Pfizer is considering raising its offer for AstraZeneca as it works with its advisers against the clock in a battle where they have just eight days left to move under British takeover rules. People familiar with the matter said, that Pfizer still hopes to get AstraZeneca into negotiations before the May 26 deadline for it to make a formal bid or walk away, but has not ruled out a hostile bid in the $100 billion-plus takeover fight.
Thanks for checking us out. Please take a look at the rest of our videos and articles.
To stay in the loop, bookmark our homepage.